Related Experiment Video
Updated: Apr 29, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Epidemiological analysis of odontogenic cysts and tumors: a 10-year retrospective study based on the 2022 WHO
Omer Faruk Gurbuz1, Dilek Menziletoglu1, Bozkurt Kubilay Isık1
1Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Necmettin Erbakan University, Konya, Turkey.
Objective:
This study aims to evaluate the epidemiological and clinico-pathological characteristics of odontogenic cysts and tumors in a Turkish subpopulation based on the 2022 WHO classification.
Study Design:
A retrospective analysis was conducted on 1050 patients treated at a regional tertiary center over a 10-year period (2015-2025). Data regarding age, sex, histopathological diagnosis, and anatomical localization were statistically evaluated.
Results:
Of the 1050 cases, 94.2% (n = 989) were odontogenic cysts and 5.8% (n = 61) were odontogenic tumors. The mean age of the cohort was 41.90 ± 16.75 years, with cysts appearing in significantly older patients compared to tumors (p < .001). Odontogenic cysts showed a male predominance (57.5%), while tumors occurred more frequently in females (65.6%). The most frequent lesions were radicular cysts (76%) and odontomas (68.9%). The posterior mandible was the primary anatomical site for both categories (44.4% for cysts; 36.1% for tumors).
Conclusion:
While the findings generally align with the global literature and the 2022 WHO criteria, the high prevalence of inflammatory cysts and specific demographic variations underscore the influence of regional dynamics and access to dental care.
Related Concept Videos
Teeth
In the bud stage, the tooth germ (an aggregation of cells) starts to form in the developing jawbone. During the cap stage, the tooth germ differentiates into enamel organ, dental papilla, and dental sac, which will later develop into the tooth's enamel, dentin...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Cancer Survival Analysis

